Anbio Biotechnology NNNN
NASDAQ NNNN
$3.72 -0.01 (-0.27%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Receivables - Net (2023 - 2025)

Updated

Anbio Biotechnology's Receivables - Net came in at $3.66 million for the quarter ended Dec 31, 2025, up 243.3% from $1.06 million a year earlier.

Analysis

Anbio Biotechnology (NNNN) Receivables - Net (2023 - 2025) Analysis & Trends

Going back to the quarter ended Dec 31, 2023, Anbio Biotechnology's Receivables - Net data covers 4 quarters.

  • Going back by year, Receivables - Net was $1.06 million in the year ended Dec 31, 2024 (-43.5%) and $1.88 million in the year ended Dec 31, 2023.
  • The five-year range for quarterly Receivables - Net is $1.06 million (the quarter ended Dec 31, 2024) to $3.72 million (the quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Anbio Biotechnology 162.72 Mn 115.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.66 Mn
Jun 30, 2025 3.72 Mn
Dec 31, 2024 1.06 Mn
Dec 31, 2023 1.88 Mn
API Access

Anbio Biotechnology Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NNNN&period=max&api_key=YOUR_API_KEY